Tryptophan

Products in Health Canada’s databases that list Tryptophan as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.

Drug products: 138; 44 authorized now
Natural health products: 0; 0 active licences
Notices of Compliance: 72
Products in all: 138

Drug products

Authorized products first.

Name	DIN	Status	Holder	Status since
20% PROSOL (0.32 G)	02141450	Marketed	Baxter Corporation	Jan 2015
APO-TRYPTOPHAN (500 MG)	02248538	Marketed	Apotex Inc.	Dec 2003
APO-TRYPTOPHAN (1 G)	02248539	Marketed	Apotex Inc.	Dec 2003
APO-TRYPTOPHAN (500 MG)	02248540	Marketed	Apotex Inc.	Dec 2003
APO-TRYPTOPHAN (750 MG)	02458721	Marketed	Apotex Inc.	Feb 2017
CLINIMIX (90 MG)	02013886	Marketed	Baxter Corporation	Nov 2013
CLINIMIX (90 MG)	02013940	Marketed	Baxter Corporation	Nov 2013
CLINIMIX (90 MG)	02046709	Marketed	Baxter Corporation	Nov 2013
CLINIMIX (90 MG)	02013932	Marketed	Baxter Corporation	Nov 2013
CLINIMIX (108 MG)	02498448	Marketed	Baxter Corporation	Apr 2022
CLINIMIX (144 MG)	02498456	Marketed	Baxter Corporation	Apr 2023
CLINIMIX (144 MG)	02498464	Marketed	Baxter Corporation	Nov 2020
CLINIMIX E (90 MG)	02014076	Marketed	Baxter Corporation	Nov 2013
CLINIMIX E (90 MG)	02013967	Marketed	Baxter Corporation	Nov 2013
CLINIMIX E (90 MG)	02142384	Marketed	Baxter Corporation	Nov 2013
CLINIMIX E (144 MG)	02498413	Marketed	Baxter Corporation	Oct 2021
CLINIMIX E (144 MG)	02498421	Marketed	Baxter Corporation	Dec 2020
ESSEPNA (0.2 G)	02510324	Marketed	Fresenius Kabi Canada Ltd	Jan 2023
OLIMEL 5.7% (0.95 G)	02352540	Marketed	Baxter Corporation	Sep 2019
OLIMEL 5.7% E (0.95 G)	02352532	Marketed	Baxter Corporation	Jan 2011
OLIMEL 7.6% (1.26 G)	02477947	Marketed	Baxter Corporation	Jul 2021
OLIMEL 7.6% E (1.26 G)	02477955	Marketed	Baxter Corporation	Oct 2018
PERIOLIMEL 2.5% E (0.42 G)	02352494	Marketed	Baxter Corporation	Feb 2011
PRIMENE 10% (200 MG)	02236875	Marketed	Baxter Corporation	Dec 2014
SMOFKABIVEN (0.1 G)	02440695	Marketed	Fresenius Kabi Canada Ltd	Sep 2015
SMOFKABIVEN ELECTROLYTE FREE (0.1 G)	02440687	Marketed	Fresenius Kabi Canada Ltd	Sep 2015
SMOFKABIVEN EXTRA NITROGEN (0.13 G)	02501813	Marketed	Fresenius Kabi Canada Ltd	May 2021
SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREE (0.13 G)	02501775	Marketed	Fresenius Kabi Canada Ltd	Jul 2021
SMOFKABIVEN PERIPHERAL (63 MG)	02456206	Marketed	Fresenius Kabi Canada Ltd	Feb 2017
TEVA-TRYPTOPHAN (500 MG)	02240333	Marketed	Teva Canada Limited	Jan 2013
TEVA-TRYPTOPHAN (500 MG)	02240334	Marketed	Teva Canada Limited	Jan 2013
TRAVASOL (180 MG)	00872296	Marketed	Baxter Corporation	Oct 2013
TRYPTAN (500 MG)	00718149	Marketed	Bausch Health, Canada Inc.	Jun 2021
TRYPTAN (1 G)	00654531	Marketed	Bausch Health, Canada Inc.	Jun 2021
TRYPTAN (500 MG)	02029456	Marketed	Bausch Health, Canada Inc.	Jun 2021
TRYPTAN (250 MG)	02239326	Marketed	Bausch Health, Canada Inc.	Jun 2021
TRYPTAN (750 MG)	02239327	Marketed	Bausch Health, Canada Inc.	Jun 2021
AMINO BOLUSES IMPROVED (140 MG)	00319333	Dormant	Professional Veterinary Laboratories	Oct 2020
AMINO SOLUTION (1 MG)	00319341	Dormant	Professional Veterinary Laboratories	Oct 2020
AMINO SOLUTION INJ (1 MG)	00395714	Dormant	Dominion Veterinary Laboratories Ltd.	Oct 2020
AMINOLEAN INJECTION (0.3 MG)	00506990	Dormant	Bimeda-MTC Animal Health Inc.	Jul 2023
AMINOSYN II (200 MG)	00742619	Dormant	Icu Medical Canada Inc	Aug 2018
AMINOSYN II (300 MG)	02126745	Dormant	Icu Medical Canada Inc	Sep 2018
APO-TRYPTOPHAN (250 MG)	02248537	Approved	Apotex Inc.	Dec 2003
2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE (45 MG)	02143267	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE CLINIMIX (45 MG)	02013975	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
2.5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 10% DEXTROSE QUICKMIX (45 MG)	02014106	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
2.5%TRAVASOL AMINO ACID INJ.W.ELEC.W.25%DEX (45 MG)	02143259	Cancelled Post Market	Clintec Nutrition Company	Aug 1998
2.75% TRAVAS. AMINO ACID INJ.W.ELECW.25%DEX (49.5 MG)	02143232	Cancelled Post Market	Clintec Nutrition Company	Aug 1998
2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE QUICKMIX (49.5 MG)	02014009	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX (49.5 MG)	02013991	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
2.75%TRAVASOL AMINO ACID INJ.W.ELEC.W.5%DEX. (49.5 MG)	02143240	Cancelled Post Market	Clintec Nutrition Company	Aug 1999
4.25% AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE QUICKMIX (76 MG)	02013908	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE (76.5 MG)	02142414	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE (76.5 MG)	02142406	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE QUICKMIX (76 MG)	02014033	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE (76.5 MG)	02142392	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX (76 MG)	02014017	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTRLYTES IN 10% DEXTROSE (76.5 MG)	02142317	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE (76.5 MG)	02142309	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
4.25% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE (76.5 MG)	02142295	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
4.25% TRAVASOL AMINO ACID WITHOUT ELECTROLYTES IN 5% DEXTROSE QUICKMIX (76 MG)	02013894	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
4.25%TRAV. AMINO ACID INJ.W.O.ELECT.5%DEXT. (76.5 MG)	02142325	Cancelled Post Market	Clintec Nutrition Company	Aug 1999
4.25%TRAVASOL AMINO ACID INJ.W.ELECW.5%DEX. (76.5 MG)	02143224	Cancelled Post Market	Clintec Nutrition Company	Aug 1999
5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE (90 MG)	02142368	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE (90 MG)	02142252	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2015
5% TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 25% DEXTROSE (90 MG)	02142244	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
8.5% FREAMINE III (130 MG)	02158647	Cancelled Post Market	B. Braun Medical AG	Apr 2012
AMINO ACID FORMULA INJ (3.8 MG)	00508365	Cancelled Post Market	Central Sales Limited	Jul 2002
AMINO ACID FORMULA INJ (3.8 MG)	00583537	Cancelled Post Market	Centravet Products	Aug 1996
AMINO ACID INJ (1 MG)	00154032	Cancelled Post Market	Ormond Veterinary Supply Ltd.	Aug 2001
AMINO ACID INJECTABLE (.7 MG)	00626368	Cancelled Post Market	Univet Pharmaceuticals Ltd.	Jun 2023
AMINO LITE (1 MG)	00609919	Cancelled Post Market	Anchor, Division Of Boehringer Ingelheim	Aug 1997
AMINO SOLUTION INJ (1 MG)	00607800	Cancelled Post Market	Multivet Ltd	Sep 1996
AMINO-JUG (0.3 MG)	02283514	Cancelled Post Market	Wyeth Animal Health, Division Of Wyeth Canada	Jul 2008
AMINOSYN (160 MG)	00454907	Cancelled Post Market	Icu Medical Canada Inc	Jan 2019
AMINOSYN 10% W ELECTROLYTES (160 MG)	00558966	Cancelled Post Market	Abbott Laboratories Co.	Aug 1999
AMINOSYN 3.5% M (56 MG)	00510629	Cancelled Post Market	Abbott Laboratories Co.	Aug 1999
AMINOSYN 5% (80 MG)	00404160	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN 7% (120 MG)	00523232	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN 8.5% (150 MG)	00613320	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN 8.5% INJECTION WITH ELECTROLYTES (150 MG)	00613339	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II 10% WITH ELECTROLYTES (200 MG)	00742651	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN II 5% INJ (100 MG)	00742643	Cancelled Post Market	Abbott Laboratories Co.	Aug 1999
AMINOSYN II 7% INJECTION (140 MG)	00742635	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN II 7% M IN 10% DEXTROSE(DUAL CHAMBER) (70 MG)	00742724	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II 7% WITH 10% DEXTROSE (70 MG)	00742740	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II 7% WITH 50% DEXTROSE (70 MG)	00742759	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II 8.5% INJECTION (170 MG)	00742627	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN II 8.5% M IN 20% DEXTROSE (DUAL CHAMBER) (85 MG)	00742716	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II 8.5% WITH 50% DEXTROSE (85 MG)	00742767	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II IN DEXTROSE INJECTION (100 MG)	00742783	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II IN DEXTROSE INJECTION (85 MG)	00839302	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II IN DEXTROSE INJECTION (85 MG)	00839310	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM (85 MG)	00851531	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM (85 MG)	00851574	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUM (70 MG)	00851566	Cancelled Post Market	Hospira Healthcare Corporation	Aug 2012
AMINOSYN RF INJECTION (165 MG)	00640131	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN-PF 10% (180 MG)	00731366	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
AMINOSYN-PF 7% (125 MG)	00731358	Cancelled Post Market	Hospira Healthcare Corporation	Jul 2016
BVS AMINO ACID SOLUTION INJ (1 MG)	00874396	Cancelled Post Market	Brock Veterinary Supply Co	Feb 2004
CLINIMIX (90 MG)	02013959	Cancelled Post Market	Baxter Corporation	Jun 2018
CLINIMIX (76 MG)	02013916	Cancelled Post Market	Baxter Corporation	Jul 2016
CLINIMIX (76 MG)	02013924	Cancelled Post Market	Baxter Corporation	Jul 2016
CLINIMIX (90 MG)	02142260	Cancelled Post Market	Baxter Corporation	Dec 2022
CLINIMIX (90 MG)	02142279	Cancelled Post Market	Baxter Corporation	Apr 2022
CLINIMIX 2.5% TRAVASOL AA WITHOUT ELECTROLYTES IN 10% DEXTROSE INJEC (45 MG)	02142333	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Aug 2007
CLINIMIX E (76 MG)	02014025	Cancelled Post Market	Baxter Corporation	Jun 2018
CLINIMIX E (90 MG)	02014084	Cancelled Post Market	Baxter Corporation	Jul 2016
CLINIMIX E (76 MG)	02014041	Cancelled Post Market	Baxter Corporation	Jun 2018
CLINIMIX E (90 MG)	02014068	Cancelled Post Market	Baxter Corporation	Mar 2021
CLINIMIX E (90 MG)	02142341	Cancelled Post Market	Baxter Corporation	Jun 2018
CLINIMIX E (90 MG)	02142376	Cancelled Post Market	Baxter Corporation	Jun 2022
DOM-TRYPTOPHAN (1 G)	02231255	Cancelled Pre Market	Dominion Pharmacal	May 2025
METABOLINE (10 MG)	00086878	Cancelled Post Market	Desbergers Ltée, Division Of Technilab Inc.	Sep 1999
NEPHRAMINE LIQ IV (200 MG)	02029464	Cancelled Post Market	B. Braun Medical AG	May 2018
NUTRINEAL PD4 (27 MG)	02230810	Cancelled Post Market	Baxter Corporation	Nov 2021
OLIMEL 3.3% E (0.55 G)	02352508	Cancelled Pre Market	Baxter Corporation	Oct 2025
OLIMEL 4.4% (0.74 G)	02352524	Cancelled Post Market	Baxter Corporation	Oct 2025
OLIMEL 4.4% E (0.74 G)	02352516	Cancelled Post Market	Baxter Corporation	Oct 2025
PHL-TRYPTOPHAN (1 G)	02236957	Cancelled Post Market	Pharmel Inc.	Oct 2016
PHL-TRYPTOPHAN (500 MG)	02262436	Cancelled Post Market	Pharmel Inc.	Oct 2016
PHL-TRYPTOPHAN (500 MG)	02262444	Cancelled Post Market	Pharmel Inc.	Oct 2016
PMS-TRYPTOPHAN (1 G)	02230202	Cancelled Post Market	Pharmascience Inc.	Jul 2025
PMS-TRYPTOPHAN (500 MG)	02240445	Cancelled Post Market	Pharmascience Inc.	Jul 2025
PMS-TRYPTOPHAN (500 MG)	02241023	Cancelled Post Market	Pharmascience Inc.	Jul 2025
PRIMENE 10%-LIQ IV (200 MG)	02161192	Cancelled Post Market	Clintec Nutrition Company	Aug 1998
QUICK MIX 2.5% TRAVASOL AA WITH ELECTROLYTES WITH 25% DEXTROSE INJEC (45 MG)	02013983	Cancelled Post Market	Baxter Corporation Clintec Nutrition Division	Jul 2000
RENAMIN (AMINO ACIDS) INJECTION (160 MG)	02020564	Cancelled Post Market	Baxter Corporation	May 2011
TEVA-TRYPTOPHAN (1 G)	02237250	Cancelled Post Market	Teva Canada Limited	Jan 2025
TRAVASOL (180 MG)	00388769	Cancelled Post Market	Baxter Corporation	Aug 2016
TRAVASOL AMINO ACID INJ 5.5% (99 MG)	00306444	Cancelled Post Market	Baxter Corporation	Aug 2007
TRAVASOL AMINO ACID INJ 8.5% (152 MG)	00306436	Cancelled Post Market	Baxter Corporation	Mar 2008
TRAVASOL E (180 MG)	00285528	Cancelled Post Market	Baxter Corporation	Oct 2017
TRAVASOL INJ WITHOUT ELECTROLYTES 5.5% (99 MG)	00388742	Cancelled Post Market	Baxter Corporation	Aug 2007
TRAVASOL INJ WITHOUT ELECTROLYTES 8.5% (152 MG)	00388750	Cancelled Post Market	Baxter Corporation	Mar 2008
VAMIN 18 ELECTROLYTE-FREE (190 MG)	02059711	Cancelled Post Market	Fresenius Kabi Ag	Jul 2006
VAMIN N (100 MG)	02065665	Cancelled Post Market	Fresenius Kabi Ag	Jul 2006

Notices of Compliance

Approvals of drug submissions that list it, newest first.

SMOFKABIVEN PERIPHERALMay 13, 2025 · NOC 35359
OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% EMarch 4, 2025 · NOC 34938
OLIMEL 4.4%; OLIMEL 5.7%; OLIMEL 7.6%March 4, 2025 · NOC 34941
CLINIMIX EJuly 19, 2024 · NOC 33675
CLINIMIX EJuly 19, 2024 · NOC 33676
CLINIMIXJuly 19, 2024 · NOC 33688
OLIMEL 4.4%; OLIMEL 5.7%; OLIMEL 7.6%July 19, 2023 · NOC 31273
OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% EJuly 19, 2023 · NOC 31274
OLIMEL 3.3% E; OLIMEL 4.4% E; OLIMEL 5.7% E; OLIMEL 7.6% E; PERIOLIMEL 2.5% EApril 19, 2021 · NOC 26092
SMOFKABIVEN ELECTROLYTE FREE; SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREEJuly 9, 2020 · NOC 23877
SMOFKABIVEN; SMOFKABIVEN EXTRA NITROGENJuly 9, 2020 · NOC 23882
TEVA-TRYPTOPHANJuly 25, 2019 · NOC 22464
AMINOSYNMay 31, 2018 · NOC 20928
AMINOSYNDecember 22, 2017 · NOC 20201
APO-TRYPTOPHANNovember 4, 2016 · NOC 18638
AMINOSYN-PF 10%; AMINOSYN-PF 7%January 7, 2016 · NOC 23269
PRIMENE 10%December 18, 2014 · NOC 16455
CLINIMIX - 4.25% (BLEND B) IN 10%; CLINIMIX - 4.25% (BLEND B) IN 25%; CLINIMIX - 5% (BLEND B) IN 16.6%; CLINIMIX - 5% (BLEND B) IN 10%; CLINIMIX - 5% (BLEND B) IN 5%; CLINIMIX - 5% (BLEND B) IN 20%; CLINIMIX - 5% (BLEND B) IN 25%; CLINIMIX - 5% (BLEND C) IN 10%; CLINIMIX - 5% (BLEND C) IN 16.6%; CLINIMIX E - 4.25% (BLEND B) IN 10%; CLINIMIX E - 4.25% (BLEND B) IN 25%; CLINIMIX E - 5% (BLEND B) IN 10%; CLINIMIX E - 5% (BLEND B) IN 16.6%; CLINIMIX E - 5% (BLEND B) IN 20%; CLINIMIX E - 5% (BLEND B) IN 25%; CLINIMIX E - 5% (BLEND C) IN 10%; CLINIMIX E - 5% (BLEND C) IN 16.6%; CLINIMIX E - 5% (BLEND C) IN 25%June 5, 2014 · NOC 15669
TRAVASOL E; TRAVASOL (BLEND B); TRAVASOL (BLEND C)May 29, 2014 · NOC 15652
AMINOSYN 5%; AMINOSYN 7%; AMINOSYN 8.5%; AMINOSYN 10%February 25, 2014 · NOC 15340
AMINOSYN-RF 5.2%February 25, 2014 · NOC 15341
AMINOSYN 8.5% WITH ELECTROLYTESFebruary 25, 2014 · NOC 15342
AMINOSYN-PF 7%; AMINOSYN-PF 7% AND 10%February 25, 2014 · NOC 15343
AMINOSYN II 7%; AMINOSYN II 8.5%; AMINOSYN II 10%; AMINOSYN II 15%February 25, 2014 · NOC 15344
TRAVASOL E; TRAVASOL (BLEND B); TRAVASOL (BLEND C)October 7, 2013 · NOC 14805
TEVA-TRYPTOPHANJanuary 2, 2013 · NOC 13975
AMINOSYN II 10%June 5, 2012 · NOC 13449
OLIMEL 3.3% WITH ELECTROLYTES; OLIMEL 4.4%; OLIMEL 4.4% WITH ELECTROLYTES; OLIMEL 5.7%; OLIMEL 5.75% WITH ELECTROLYTES; PERIOLIMEL 2.5% WITH ELECTROLYTESDecember 22, 2011 · NOC 12890
AMINOSYN II 15% (SULFITE FREE)September 27, 2010 · NOC 11746
PERIOLIMEL 2.5% E; OLIMEL 3.3% WITH ELECTROLYTES; OLIMEL 4.4%; OLIMEL 4.4% WITH ELECTROLYTES; OLIMEL 5.7%; OLIMEL 5.7% WITH ELECTROLYTESJune 28, 2010 · NOC 11567
AMINOSYN II 7%; AMINOSYN II 8.5%; AMINOSYN II 10%June 19, 2009 · NOC 10262
AMINOSYN RFJune 19, 2009 · NOC 10263
AMINOSYN 8.5% WITH ELECTROLYTESJune 19, 2009 · NOC 10264
AMINOSYN PF 7%; AMINOSYN PF 10%June 19, 2009 · NOC 10265
AMINOSYN 5%; AMINOSYN 7%; AMINOSYN 8.5%; AMINOSYN 10%June 19, 2009 · NOC 10266
AMINOSYN II 10%; AMINOSYN II 15%June 6, 2008 · NOC 9590
AMINOSYN RF INJECTIONJanuary 26, 2006 · NOC 7709
AMINOSYN 8.5% INJ WITH ELECTROLYTESJanuary 26, 2006 · NOC 7710
PHL-TRYPTOPHANDecember 13, 2004 · NOC 5994
PHL-TRYPTOPHANDecember 13, 2004 · NOC 5995
TRYPTANOctober 13, 2004 · NOC 5552
RATIO-TRYPTOPHANOctober 13, 2004 · NOC 5555
AMINOSYN II 7% M IN 10% DEXTROSE (DUAL CHAMBER); AMINOSYN II 8.5% M IN 20% DEXTROSE (DUAL CHAMBER)June 8, 2004 · NOC 3768
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUMJune 8, 2004 · NOC 3769
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUMJune 8, 2004 · NOC 3773
AMINOSYN II 10% WITH ELECTROLYTESJune 8, 2004 · NOC 3774
AMINOSYN-PF 7%; AMONISYN-PF 10%June 8, 2004 · NOC 3776
AMINOSYN II 10%; AMINOSYN II 15%June 8, 2004 · NOC 3777
AMINOSYN II 7%; AMINOSYN II 8.5%; AMINOSYN II 10%June 8, 2004 · NOC 3778
AMINOSYN 5%; AMINOSYN 7%; AMINOSYN 8.5%; AMINOSYN 10%June 8, 2004 · NOC 3779
AMINOSYN II 7% WITH 10% DEXTROSE; AMINOSYN II 7% WITH 50% DEXTROSE; AMINOSYN II 8.5% WITH 50% DEXTROSEJune 4, 2004 · NOC 4274
AMINOSYN II 10% WITH 50% DEXTROSEJune 4, 2004 · NOC 4277
TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN DEXTROSE CLINIMIXOctober 17, 2003 · NOC 435
TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES IN DEXTROSE CLINIMIXOctober 17, 2003 · NOC 442
PMS-TRYPTOPHANJanuary 14, 2003 · NOC 1750
20% PROSOLOctober 30, 2001 · NOC 2209
TRAVASOL 20% - LIQ IVApril 6, 1999 · NOC 1843
VAMIN 14; VAMIN 14 ELECTROLYTE FREE; VAMIN 18 ELECTROLYTE FREESeptember 4, 1997 · NOC 6023
VAMIN NSeptember 4, 1997 · NOC 6024
PMS-TRYPTOPHANMay 15, 1997 · NOC 4171
DOM-TRYPTOPHANMay 12, 1997 · NOC 4170
NUTRINEAL PD4February 27, 1997 · NOC 3275
PMS-TRYPTOZANEDecember 11, 1996 · NOC 4498
TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES AND DEXTROSEJanuary 30, 1996 · NOC 6042
TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES AND DEXTROSEJanuary 30, 1996 · NOC 6043
TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES AND WITH DEXTROSEJanuary 30, 1996 · NOC 6075
TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES AND WITH DEXTROSEJanuary 30, 1996 · NOC 6076
TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES WITH DEXTROSENovember 25, 1994 · NOC 5954
TRAVASOL AMINO ACID INJECTION WITHOUT ELECTROLYTES WITH DEXTROSENovember 21, 1994 · NOC 5955
AMINOSYN II (15%)August 25, 1994 · NOC 5163
TRYPTANFebruary 23, 1994 · NOC 5622
VAMIN NJanuary 14, 1994 · NOC 5899